NCT05005494 is a Phase 4 clinical trial of Magnesium sulfate IV in Anesthesia, sponsored by University of Liege.

Who is sponsoring NCT05005494?

NCT05005494 is sponsored by University of Liege.

What drugs are being tested in NCT05005494?

Interventions in NCT05005494: Magnesium sulfate IV, Placebo.

What condition does NCT05005494 study?

NCT05005494 studies Anesthesia.

Is NCT05005494 still recruiting?

NCT05005494 is currently status unknown. Last updated 19 August 2021.

Last reviewed 2021-08-19 · How we verify

NCT05005494

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypnotic and Anti-nociceptive Components of Magnesium

Status unknown Phase 4 Last updated 19 August 2021

What this trial tests

Phase 4 trial testing Magnesium sulfate IV in Anesthesia in 20 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
1 November 2021

1 December 2021

Quick facts

Lead sponsor	University of Liege
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	supportive care
Enrollment	20
Start date	1 September 2021
Primary completion	1 November 2021
Estimated completion	1 December 2021
Sites	1 location across Belgium

Drugs / interventions tested

Magnesium sulfate IV — full drug profile →
Placebo

Conditions studied

Anesthesia — all drugs for Anesthesia →

Sponsor

University of Liege

Who can join

18 and older, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to evaluate the effect of magnesium on the hypnotic effect of propofol.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other University of Liege trials

Trials by the same sponsor.

NCT07523178 — Effects of a Targeted Prevention Program on Change-of-Direction Biomechanics and Performance in Elite Female Soccer Play · NA · not yet recruiting
NCT07472400 — Mobility, Strength, and Functional Outcomes Before Surgery, at 3 Months, and at 6 Months After Hip Arthroscopy for Femor · not yet recruiting
NCT07331779 — Effect of tDCS Timing on Motor Recovery in Acute Stroke Rehabilitation · NA · not yet recruiting
NCT07237893 — Impact of a Physical Activity Intervention on Cardiometabolic Health, Mental Health, and Lifestyle Factors. · NA · not yet recruiting
NCT06964282 — Iliopsoas (IPB) and Pericapsular Nerve Group (PENG) Blocks Comparison on Analgesia and Recovery After Total Hip Arthropl · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05005494 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Liege
Last refreshed: 19 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05005494.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing